Skip to main content

Table 1 Patient characteristics and clinical laboratory data

From: Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate

Age (years) 32 (8–73)
Gender [male/female] 12/4
Height (cm) 165 (124.4–178)
Body weight (kg) 50.8 (26.6–75.6)
WBC 5.8 (1.3–22.5)
RBC 3.4 (2.8–4.6)
HGB 10.6 (8.3–15.1)
HCT 31.6 (24.1–41.7)
CRP (mg/dL) 0.20 (0.02–1.85)
Alb (g/dL) 3.8 (2.7–4.5)
TP (g/dL) 6.4 (4.7–7.4)
T.Bil (mg/dL) 0.66 (0.19–1.74)
AST (IU/L) 28.2 (14.2–177.7)
ALT (IU/L) 33.8 (12.5–198.4)
ALP 322.0 (189.0–514.0)
γ-GTP 49.4 (11.1–222.8)
BUN (mg/dL) 12.2 (2.9–30.6)
SCr (mg/dL) 0.60 (0.23–2.05)
CCr 99.6 (43.5–219.1)
  1. Data are expressed as median and interquartile range unless otherwise stated